60
28
Growth Score
-13 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
930979
QBiotics discovers and develops plant-derived cell signaling molecules to treat challenging medical conditions in humans and animals.
- Victoria Gordon: Founder, CEO, and Managing Director
- Paul Reddell: Executive Director and Chief Scientific Officer
About the Company
QBiotics focuses on two unique clinical assets: oncology and wound healing. Their lead oncology product, tigilanol tiglate, is a novel small molecule that is administered intratumorally and has the potential to treat a broad range of solid tumors, either as a monotherapy or in combination with checkpoint inhibitor drugs. They have proven ability to
successfully partner and to commercialise their products.
